Elmiron-Related Eye Injuries and Vision Problems

Free Case Evaluation

You must read the following notice before sending an e-mail message to Robins Kaplan LLP.

Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.

If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.

By accepting these terms, you are confirming that you have read and understood this important notice.

Diagnosed with an Eye Injury or Vision Problem? Our Lawyers Are Ready to Assist You

Robins Kaplan LLP is investigating reports of vision problems and eye injuries associated with use of the drug Elmiron. If you have been prescribed Elmiron and developed an eye injury or vision problem, contact us at 1.800.610.7562 for a free evaluation. 

Elmiron is a drug prescribed to treat interstitial cystitis (also known as painful bladder syndrome). Manufactured by Janssen, Elmiron is the brand-name for a drug called pentosan polysulfate sodium.

Elmiron has been linked with certain eye injuries in several medical journals, including, Ophthalmology,1 JAMA Ophthalmology,2 the British Journal of Ophthalmology,3 and Review of Ophthalmology.4

One of the eye injuries linked with Elmiron is commonly called maculopathy or macular degeneration, a problem with the central part of the retina. Maculopathy can permanently impair vision and can cause a range of symptoms, including:

  • Central vision loss
  • Blurred, dimmed, or spotty vision
  • Difficulty reading
  • Difficulty adjusting to low light
  • Pain in the eye 

How Robins Kaplan Law Firm Can Help With Your Elmiron Lawsuit

Our nationally recognized Mass Tort Attorneys assist clients who are seriously injured by dangerous and defective products, and we are available to evaluate your potential claim against the manufacturers of Elmiron. Contact us for a free and confidential evaluation today. To get started, call 1.800.610.7562 or fill out our online contact form above.

Trouble reading this page? Below is an Audio-Visual option for information on Elmiron.

1 Pearce WA, Chen R, Jain N. Pigmentary Maculopathy Associated with Chronic Exposure to Pentosan Polysulfate Sodium. Ophthalmology. 2018 Nov;125(11):1793-1802.
2 Hanif AM, Armenti ST, Taylor SC, et al. Phenotypic Spectrum of Pentosan Polysulfate Sodium-Associated Maculopathy: A Multicenter Study. JAMA Ophthamol. 2019 Sep 5. Doi: 10.1001/jamaophthalmol.2019.3392. [Epub ahead of print].
3 Jain N, Li AL, Yu Y, VanderBeek BL. Association of macular disease with long-term use of pentosan polysulfate sodium: findings from a US cohort. Br J Ophthalmol. 2019 Nov 6. Doi: 10.1136/bjophthalmol-2019-314765. [Epub ahead of print].
4 Hanif AM, Jain N. Clinical Pearls for a New Condition: Pentosan polysulfate therapy, a common treatment for interstitial cystitis, has been associated with a maculopathy. Review of Ophthalmolgy. 2019 July 10.